NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Neurofibromatosis type 1 (NF1) affects about one in 3,500 people in all ethnic groups. Most NF1 patients have private loss-of-function mutations scattered along the NF1 gene. Here, we present an original NF1 investigation strategy and report a comprehensive mutation analysis of 565 unrelated patients from the NF-France Network. A NF1 mutation was identified in 546 of the 565 patients, giving a mutation detection rate of 97%. The combined cDNA/DNA approach showed that a significant proportion of NF1 missense mutations (30%) were deleterious by affecting pre-mRNA splicing. Multiplex ligation-dependent probe amplification allowed the identification of restricted rearrangements that would have been missed if only sequencing or microsatellite analysis had been performed. In four unrelated families, we identified two distinct NF1 mutations within the same family. This fortuitous association points out the need to perform an exhaustive NF1 screening in the case of molecular discordant-related patients. A genotype-phenotype study was performed in patients harboring a truncating (N = 368), in-frame splicing (N = 36), or missense (N = 35) mutation. The association analysis of these mutation types with 12 common NF1 clinical features confirmed a weak contribution of the allelic heterogeneity of the NF1 mutation to the NF1 variable expressivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NF1 Gene Contains Hotspots for L1 Endonuclease-Dependent De Novo Insertion
Wimmer, K., Callens, T., Wernstedt, A., & Messiaen, L. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002371 · Cited by 107 · cited 2×
“…at both cDNA and DNA levels enables to detect a broader spectrum of mutations than any single level approach, and provides a greater understanding of their molecular pathogenesis [Messiaen et al., 2000; Messiaen and Wimmer, 2008; Pros et al., 2008; Valero et al., 2011; Wimmer et al., 2011].”
Background
Cited by
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1
Evans, D. G. R., Salvador, H., Chang, V. Y., Erez, A., Voss, S. D., Schneider, K. W., Scott, H. S., Plon, S. E., & Tabori, U. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0589 · Cited by 178
Metadata
- Authors
- Sabbagh, A., Pasmant, E., Imbard, A., Luscan, A., Soares, M., Blanché, H., Laurendeau, I., Ferkal, S., Vidaud, M., Pinson, S., Bellanné-Chantelot, C., Vidaud, D., the members of the NF France Network, Parfait, B., & Wolkenstein, P.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2013-08-26
- Volume
- 34
- Issue
- 11
- Pages
- 1510-1518
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2023636715
- Cited by
- 179
- References
- 1
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience. https://app.cochat.ai/papers/10.1002/humu.22392
- The paper
- Sabbagh, A., Pasmant, E., Imbard, A., Luscan, A., Soares, M., Blanché, H., Laurendeau, I., Ferkal, S., Vidaud, M., Pinson, S., Bellanné-Chantelot, C., Vidaud, D., the members of the NF France Network, Parfait, B., & Wolkenstein, P. (2013). NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience. Human Mutation. https://doi.org/10.1002/humu.22392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.